Tegaserod was stable in this medium for up to three days at 20-25 °C or 5 °C, and the dissolution profile of a crushed tablet in water was the same as that of the intact tablet.

Abstract and Introduction Abstract Background: Small intestinal bacterial overgrowth (SIBO) is a condition in which excessive levels of bacteria, mainly the colonic-type species are present in the ...

Patient responses to tegaserod treatment for the outcome measure of PVR urine volume can be found in Figure 1 and Table 2. After tegaserod treatment, the average PVR was significantly reduced when ...

Prokinetic agents such as metoclopramide, tegaserod, domperidone, and erythromycin are generally stopped 2 d before the test unless the test is done to assess the efficacy of these drugs. Medications ...

Medically reviewed by Kumkum S. Patel, MD Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) are different conditions, but they may both occur in the same person. GERD ...

Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of ...

It is increasingly perceived that gut host–microbial interactions are important elements in the pathogenesis of functional gastrointestinal disorders (FGID). The most convincing evidence to date is ...

36 Muller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Rüegg P. Tegaserod, a 5-HT (4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal ...